BORTEZOMIB FRESENIUS KABI 2,5 mg POLVO PARA SOLUCION INYECTABLE EFG
BORTEZOMIB FRESENIUS KABI 2,5 mg POLVO PARA SOLUCION INYECTABLE EFG
Pending
Register Number
1191397003
Prescription Type
Uso Hospitalario
Authorization Date
Jun 23, 2021
Dosage Form
POLVO PARA SOLUCIÓN INYECTABLE
Route: VÍA INTRAVENOSA
Product Details
Detailed information about this CIMA AEMPS approved pharmaceutical product.
Basic Information
Key regulatory and product classification details
Regulatory Details
Register Number1191397003
EMA Approved
Yes
Drug Classification
✓
Generic
Yes
✗
Orphan
No
✗
Biosimilar
No
✗
Commercialized
No
CIMA AEMPS Classification
INGREDIENTS (1)
BORTEZOMIBActive
Quantity: 2,5 mg
Name: BORTEZOMIB
ATC CLASSIFICATION (3)
L01X
L01XG
L01XG01